CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Inpeco S.A. recalls FlexLab X (FXX) System and 1 more

Read the official FDA notice

Published
15 Oct 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

FlexLab X (FXX) System. Potassium Test System. in vitro diagnostic

FlexLab (FLX) System. Potassium Test System. in vitro diagnostic

Brand / company
Inpeco S.A.
Codes / lots
PN: FLX-056-40; UDI: 07640172344002: Serial No. FXX.0015. | PN: FLX-056-01, FLX-056-11; UDI: 07640172340004: Serial No. FLX.0204, FLX.0205, FLX.0209, FLX.0210, FLX.0216, FLX.0220, FLX.0221, FLX.0222.
Distribution
US distribution to CA & NY.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 15 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.